GlassScriptPhysician profile
Tara L Scott
NPI 1972535862
$3,523.39
in general payments reported to CMS, 2019-2025
29 companies · $574 in 2025
The $574 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $323 · 2020: $149 · 2021: $90.49 · 2022: $630 · 2023: $499 · 2024: $1,258 · 2025: $574.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,647 · Travel and Lodging: $684.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,647.00 |
| Travel and Lodging | $684.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $833.14 | 2024-2025 | |
| Paratek Pharmaceuticals, INC. | $330.76 | 2021-2025 | Nuzyra |
| Aroa Biosurgery Incorporated | $284.34 | 2022-2024 | |
| Stryker Corporation | $229.80 | 2019-2024 | Augment Injectable, Viaflow |
| Abbvie INC. | $223.44 | 2024-2025 | |
| Medtronic, INC. | $206.13 | 2022 | |
| Depuy Synthes Sales INC. | $190.72 | 2023-2025 | Foot Osteotomy Wedge System, Motoband |
| Pfizer INC. | $166.22 | 2019-2020 | |
| Medical Device Business Services, INC. | $114.60 | 2025 | Motoband |
| Kerecis Limited | $108.95 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Smith+Nephew, INC. | $82.32 | 2019-2025 | Renasys Touch, Pico 7, Collagenase Santyl |
| Bioventus LLC | $73.28 | 2019-2021 | |
| Medartis INC. | $71.02 | 2022 | |
| Zimmer Biomet Holdings, INC. | $70.76 | 2020-2022 | |
| Acera Surgical, INC. | $60.64 | 2024-2025 | Restrata Wound Matrix |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $58.30 | 2022 | |
| Zyla Life Sciences, INC. | $57.56 | 2019-2020 | |
| Next Science LLC | $46.63 | 2023 | Surgx, Blastx, Xperience |
| Paragon 28, INC. | $46.05 | 2020-2022 | |
| Nabriva Therapeutics, Plc | $41.15 | 2021-2022 | |
| Ibsa Pharma INC. | $38.60 | 2024 | Tirosint, Licart |
| Horizon Therapeutics Plc | $35.36 | 2019-2023 | Krystexxa |
| Alfasigma USA, INC. | $28.96 | 2020-2022 | |
| Wright Medical Technology, INC. | $25.42 | 2020 | |
| Mimedx Group, INC. | $24.10 | 2025 | |
| Amgen INC. | $23.81 | 2025 | Krystexxa |
| Convatec INC. | $22.39 | 2025 | |
| Grt US Holding, INC. | $17.96 | 2021 | |
| Arthrosurface Incorporated | $10.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.